000 01139 a2200301 4500
005 20250517015556.0
264 0 _c20160112
008 201601s 0 0 eng d
022 _a1759-4804
024 7 _a10.1038/nrrheum.2015.16
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchneider, Matthias
245 0 0 _aConnective tissue diseases: SLE classification: plus ça change, plus c'est la même chose.
_h[electronic resource]
260 _bNature reviews. Rheumatology
_cMay 2015
300 _a262-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aCross-Sectional Studies
650 0 4 _aDisease Management
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aLupus Erythematosus, Systemic
_xclassification
650 0 4 _aSensitivity and Specificity
700 1 _aLiang, Matthew H
773 0 _tNature reviews. Rheumatology
_gvol. 11
_gno. 5
_gp. 262-4
856 4 0 _uhttps://doi.org/10.1038/nrrheum.2015.16
_zAvailable from publisher's website
999 _c24628726
_d24628726